Cargando…

Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia

BACKGROUND: Malaria caused by Plasmodium vivax and Plasmodium falciparum is among the major public health problems in most endemic areas of the world. Artemisinin-based combination therapy (ACT) has been recommended as a first-line treatment for uncomplicated Plasmodium falciparum malaria almost in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belew, Sileshi, Suleman, Sultan, Mohammed, Tesfaye, Mekonnen, Yimer, Duguma, Markos, Teshome, Henok, Bayisa, Bikila, Wynendaele, Evelien, D’Hondt, Matthias, Duchateau, Luc, De Spiegeleer, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628471/ https://www.ncbi.nlm.nih.gov/pubmed/31307475 http://dx.doi.org/10.1186/s12936-019-2872-1

Ejemplares similares

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
por: Belew, Sileshi, et al.
Publicado: (2020)

Quality-by-Design Principles Applied to the Establishment of a Pharmaceutical Quality Control Laboratory in a Resource-Limited Setting: The Lab Water
por: Suleman, Sultan, et al.
Publicado: (2022)

Assessment of Efficacy and Quality of Two Albendazole Brands Commonly Used against Soil-Transmitted Helminth Infections in School Children in Jimma Town, Ethiopia
por: Belew, Sileshi, et al.
Publicado: (2015)

A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products
por: Suleman, Sultan, et al.
Publicado: (2013)

Gas chromatographic method for the determination of lumefantrine in antimalarial finished pharmaceutical products
por: Suleman, Sultan, et al.
Publicado: (2015)

Dissolution Profile Evaluation of Eight Brands of Metformin Hydrochloride Tablets Available in Jimma, Southwest Ethiopia
por: Umeta, Belachew, et al.
Publicado: (2021)

Quality of Medicines Commonly Used in the Treatment of Soil Transmitted Helminths and Giardia in Ethiopia: A Nationwide Survey
por: Suleman, Sultan, et al.
Publicado: (2014)

In vitro comparative quality assessment of different brands of norfloxacin tablets available in Jimma, Southwest Ethiopia
por: Hambisa, Solomon, et al.
Publicado: (2019)

Ethnobotanical Assessment and Physicochemical Properties of Commonly Used Medicinal Plants in Jimma Zone, Southwest Ethiopia: Traditional Healers Based Cross-Sectional Study
por: Siraj, Jafer, et al.
Publicado: (2020)

Degradation kinetics of artesunate for the development of an ex-tempore intravenous injection
por: Gashe, Fanta, et al.
Publicado: (2022)

Implementation of a single quad MS detector in routine QC analysis of peptide drugs()
por: D’Hondt, Matthias, et al.
Publicado: (2016)

The clinical efficacy of artemether/lumefantrine (Coartem(®))
por: Makanga, Michael, et al.
Publicado: (2009)

Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine
por: Verbeken, Mathieu, et al.
Publicado: (2011)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
por: Ali, Shabana, et al.
Publicado: (2010)

Quality evaluation of synthetic quorum sensing peptides used in R&D
por: Verbeke, Frederick, et al.
Publicado: (2015)

LC–UV/MS quality analytics of paediatric artemether formulations
por: Vandercruyssen, Kirsten, et al.
Publicado: (2014)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
por: Prah, James, et al.
Publicado: (2016)

Efficacy of artemether–lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia
por: Mekonnen, Seleshi Kebede, et al.
Publicado: (2015)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019
por: Dimbu, Pedro Rafael, et al.
Publicado: (2021)

Derringer desirability and kinetic plot LC-column comparison approach for MS-compatible lipopeptide analysis
por: D’Hondt, Matthias, et al.
Publicado: (2014)

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria
por: Tchaparian, Eskouhie, et al.
Publicado: (2016)

Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia
por: Eshetu, Teferi, et al.
Publicado: (2012)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
por: Valecha, Neena, et al.
Publicado: (2009)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
por: Patrocínio-Jesus, Rita, et al.
Publicado: (2019)

Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali
por: Diarra, Modibo, et al.
Publicado: (2021)

Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
por: Amponsah, Emmanuel Kofi, et al.
Publicado: (2021)

Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
por: Nyangulu, Wongani, et al.
Publicado: (2023)

Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
por: Ocan, Moses, et al.
Publicado: (2023)

Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether‐Lumefantrine for Uncomplicated Malaria
por: Chotsiri, Palang, et al.
Publicado: (2019)

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022)

Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) for the Treatment of Uncomplicated Falciparum Malaria in Africa: A Systematic Review
por: Derbie, Awoke, et al.
Publicado: (2020)

Analytical quality-by-design approach for sample treatment of BSA-containing solutions
por: Taevernier, Lien, et al.
Publicado: (2015)

Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study
por: Ebstie, Yehenew A., et al.
Publicado: (2015)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
por: Sipilanyambe, Naawa, et al.
Publicado: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
por: Zurovac, Dejan, et al.
Publicado: (2008)

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
por: Gürkov, Robert, et al.
Publicado: (2008)

Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children
por: Abdulla, Salim, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4jdvor3huqbd0jpq4i4cfc9gpk